Scientists probe Brain's 'Early Warning' spot for Alzheimer's
NCT ID NCT06880510
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at a small part of the brain called the locus coeruleus, which may be one of the first areas damaged in Alzheimer's disease. Researchers will use brain scans, eye tracking, and a mild nerve stimulation device to measure how this area affects attention and memory in 150 healthy adults. The goal is to better understand how the brain ages and find early clues to Alzheimer's.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcutaneous auricular vagus nerve stimulator (taVNS)
What this could lead to
If successful, this could help identify early signs of Alzheimer's disease and point toward ways to preserve cognitive function.
What could go wrong
This is an early-stage observational study, not a treatment trial. It may not lead to direct benefits for participants, and results may not apply to all people.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cornell University
Ithaca, New York, 14850, United States